Previous close | 2,250.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 2,400.00 x N/A |
Day's range | 2,250.00 - 2,250.00 |
52-week range | 1,776.00 - 2,250.00 |
Volume | |
Avg. volume | 1 |
Market cap | 219.672B |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 14.99 |
EPS (TTM) | 150.08 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Using the 2 Stage Free Cash Flow to Equity, DaVita fair value estimate is US$119 DaVita's US$135 share...
Centene's (CNC) subsidiary wins contract from the Kansas Department of Administration to continue providing comprehensive healthcare services to the KanCare program's members.
Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.